This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results.
Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study
Cancers · 2025
Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results
npj Precision Oncology · 2025
Latest funding
- $761,176
Cavitation enhanced chemoimmunotherapy in a triple negative breast cancer setting
CIHR · 2026 · Co-investigator
- $67,430
Investigating the role of a novel gene FAM72 in breast cancer
CIHR · 2025 · Nominated PI
- $100,000
A trial to evaluate the safety and feasibility of blood-brain brain opening using MRI-guided focused ultrasound in the treatment of Her2-positive breast cancer brain metastases
CIHR · 2020 · Co-investigator
6 publications.
Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results.
Roseshter T, Klemantovich A, Lafleur J, Lan C, Cavallone L, Bozek K, Guay J, Elebute O, Jenna S, Ouellette R, McNamara S, Boileau JF, Pelmus M, Brackstone M, Pezo R, Ng T, Aguilar-Mahecha A, Basik M
Validation of a Quantitative Ultrasound Texture Analysis Model for Early Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: A Prospective Serial Imaging Study
Moore-Palhares D, Sannachi L, Chan AW, Dasgupta A, DiCenzo D, Gandhi S, Pezo R, Eisen A, Warner E, Wright F
Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results
Moore-Palhares D, Alberico D, Chan AW, DiCenzo D, Sannachi L, Dasgupta A, Yip J, Pena MLA, Gandhi S, Pezo R
Validation of Quantitative Ultrasound and Texture Derivative Analyses-Based Model for Upfront Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Chan AW, Sannachi L, Moore-Palhares D, Dasgupta A, Gandhi S, Pezo R, Eisen A, Warner E, Wright FC, Hong NL
Improving Care for Older Adults with Cancer in Canada: A Call to Action.
Cook S, Alibhai S, Mehta R, Savard MF, Mariano C, LeBlanc D, Desautels D, Pezo R, Zhu X, Gelmon KA, Hsu T
Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline
Blanchette P, Sivajohanathan D, Bartlett J, Eisen A, Feilotter H, Pezo R, Turashvili G, Williams P
Cavitation enhanced chemoimmunotherapy in a triple negative breast cancer setting
Principal investigators: Goertz, David E
Keywords: Breast Cancer; Cavitation; Chemotherapy; Focused Ultrasound; Immunotherapy; Microbubbles; Ultrasound
Investigating the role of a novel gene FAM72 in breast cancer
Principal investigators: Pezo, Rossanna C
Keywords: Cancer
A trial to evaluate the safety and feasibility of blood-brain brain opening using MRI-guided focused ultrasound in the treatment of Her2-positive breast cancer brain metastases
Principal investigators: Lipsman, Nir
Keywords: Brain Metastases; Breast Cancer; Focused Ultrasound; Her2; Image-Guided Surgery; Indium-111; Trastuzumab
A multi institutional study evaluating the role of the gut microbiome on immune checkpoint inhibitor efficacy and toxicity in advanced solid tumors
Principal investigators: Martin, Alberto; Butler, Marcus O; Pezo, Rossanna C; Siu, Lillian
Keywords: Breast Cancer; Colitis; Gut Microbiome; Head And Neck Cancers; Immune Checkpoint Inhibitors; Immunotherapy; Melanoma; Solid Tumors
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Oncology
- Immunology
- Physics
- Department of Surgery
- Social Studies of Medicine
- Li Ka Shing Knowledge
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Andrea Eisen
Faculty
4 shared papers, latest 2025
Andrea Eisen
Oncology
4 shared papers, latest 2025
Maureen Trudeau
Physics
3 shared papers, latest 2025
Daniel Moore Freitas Palhares
Oncology
3 shared papers, latest 2025
Nicole Look Hong
Department of Surgery
2 shared papers, latest 2025
Marie-France Savard
Faculty
1 shared papers, latest 2024
Frances Wright
Faculty
1 shared papers, latest 2025
Muriel Brackstone
Faculty
1 shared papers, latest 2026
Mark Basik
Social Studies of Medicine
1 shared papers, latest 2026
Shabbir Alibhai
Li Ka Shing Knowledge
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.